3 completed, 1 active not recruiting, 1 unknown. 2 Phase 2, 1 Early Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Technetium Tc 99m Medronate: new trials by email Literature Review of Technetium Tc 99m Medronate trials Research Report on Technetium Tc 99m Medronate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Ra-223 in PSMA PET Optimally Selected Patients Radium-223, PSMA Positron Emission Tomography (PET) Scan, Technetium Tc 99M Medronate - Castration-Resistant Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone | Phase 2 | Active not recruiting | University of California, San Francisco | 2 | 2024-08-30 | 2026-01-14 |
| Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies Tc-99m MDP and gamma camera - Bone Metastases, Urogenital Cancer | Unknown | Assiut University | 70 | 2022-12-01 | 2022-10-27 | |
| Diagnostic Performance and Safety of 18F-NaF-PET/CT in Bone Metastases Compared With 99mTc⁃MDP-BS±SPECT Sodium Fluoride F-18 Injection, Technetium[99mTc] Methylenediphosphonate Injection - Bone Metastases | Phase 3 | Completed | HTA Co., Ltd. | 280 | 2021-03-29 | 2022-11-14 |
| Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer magnetic resonance imaging, fluorine F 18 sodium fluoride, positron emission tomography - Bone Metastases, Recurrent Prostate Cancer | Early Phase 1 | Completed | National Cancer Institute (NCI) | 50 | 2010-03-01 | 2014-07-02 |
| Combined 18F-NaF/18F-FDG PET/MRI for Detection of Skeletal Metastases Bone scan, 99mTc-methyl diphosphonate, Positron Emission Tomography (PET) scan - Cancer | Phase 2 | Completed | Stanford University | 114 | 2006-01-01 | 2023-12-12 |
Prostatic Neoplasms (3) · Breast Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1) · Urogenital Neoplasms (1)
Assiut University (1) · HTA Co., Ltd. (1) · National Cancer Institute (NCI) (1) · Stanford University (1) · University of California, San Francisco (1)
United States (3) · China (1)
Andrei Iagaru, MD (1) · HebatAllah A Askar, Lecturer (1) · Maram M Shafeek, Resident (1) · Mukesh Harisinghani (1) · Rehab M Helmy, Lecturer (1) · Samir S Mohamed, Professor (1) · Thomas A Hope, MD (1)
PMID 23455520, PMID 26405167, PMID 26956325, PMID 31236756
N01CM37120 (1), P30CA006516 (1)